Cholinergic agonist Flashcards
Exam 4
Classifying Ach receptor agonist
- direct acting agonist: bind and activate ACh receptors and facilitate ACh signal transduction
- indirect acting agonist: increase synaptic concentration of ACH by inhibiting cholinesterase
Direct acting Ach receptor agonist
- Bethanechol (M): GI & urinary stimulation (3 Bs - bethanechol, bowel, bladder)
- Carbachol (N &M): constricts pupil and relieves IOP in glaucoma
- Methacholine (M): challenge test for asthma (diagnoistic procedure ONLY)
- Pilocarpine (M): glaucoma, xerostomia
- Cevimeline (M): xerostomia
ACh effect on eye
- contraction of iris sphincter causes miosis (constriction of pupil)
- contraction of ciliary body which controls accommodation ( decrease IOP)
- combination of those effects drains anterior chamber of eye to help glaucoma.
Cardiovascular effect of ACh
- heart depends on homeostatic mechanisms and dose
- heart wants to decrease HR and cardiac output and decrease BP
- clinically don’t use drugs with these effects in heart disease
- cardiac side effects occur when muscarinic drugs are given for other reasons
Respiratory effect of ACh
- BRONCHOCONSTRICTION: makes it harder to breath
- stimulates secretion of mucus in tracheobronchial tree: fills airways with mucus - makes harder to breath
- clinically: not used for the effect - avoid with asthma and obstructive lung disease
GI effects on ACh
- increase secretion of GI tract: salivary glands and gastric glands
- peristalsis of intestine are increase and sphincters are released
GU effects of ACh
- ACh stimulate the bladder muscle (contraction) and relaxes the sphincter
- promotes emptying of bladder
- Clinically: use if nerves to bladder are not working
- high doses of these agonist can produce urinary incontinence
Additional effects on glands of ACh
-increase sweat, lacrimal, and nasopharyngeal glands secretion
Nicotine organ effects
- prototype for drugs that just stimulate the nicotinic receptor
- nicotinic receptors are present in CNS, ganglion in PNS, SNS, and neuromuscular junction so a lot happens when they get activated
CNS effects of Nicotine
- low does increases alertness
- higher doses cause tremor, emesis, increase respiration and coma
- addiction results from receptor stimulation in certain brain areas
Ganglion effects of nicotine
- initially looks like stimulating PNS and SNS at the same time and the effect that occurs depends on which on wins out
- cardiac effects: SNS response usually wins so get increased HR and BP
- GI and GU: PNS ususally wins so get n/v/d and urination
Skeletal neuromuscular junction effects of nicotine
- initally voluntary muscles contract, but the nicotine keeps stimulating the receptor so the muscle never recovers b/c constantly stimulated - paralysis
- clinically: muscle paralysis during anesthesia for surgery
Adverse reactions of ACh receptors
- Muscarinic: SLUDGE M (salivation, lacrimation, urination, defecation, gastric emptying, emesis, miosis)
- Nicotinic: MTWTF (muscle cramps, tachycardia, weakness, twitching, fasciculation)
Indirect acting ACh receptor agonist
- cholinesterase inhibitors
- divided into 2 groups: reversible and irreversible
Reversible cholinesterase inhibitors
- quaternary compounds
- Donepezil, galantamine, rivastigmine: Alzheimer’s
- Neostigmine: myasthenia gravis, reversal of anesthetics
- Physostigmine: antidote for anticholinergic toxicity
- Pyridostigmine: myasthenia gravis, reversal of anesthetics
Irreversible cholinesterase inhibitors
- organophosphates
- harder to do adjustments
- Echothiophate: glaucoma
- Malathion: lice
Absorption of indirect cholinesterase inhibitors
- reversible: topical absorption is poor and they don’t get into CNS very well
- irreversible: topical absorption is excellent and get into CNS (highly lipid soluble), good at killing bugs, chemical warfare
CNS & indirect cholinesterase inhibitors
- low dose have an alerting effect
- high dose cause seizures, respiratory depression, coma
- clinically: used in low doses to help Alzheimer’s
Neuromuscular junction & indirect cholinesterase inhibitors
- increase ACh in synapse
- Clinically: myasthenia gravis and reverse muscle paralysis
- myasthenia gravis: disease where the immune system destroys ACh receptors in CNS - drugs help to increase ACh at receptors that are left
- reverse muscle paralysis: drugs increase the concentration of ACh at the receptor pushing off the paralyzing drug binding to the receptor
Toxicity of indirect cholinesterase inhibitors
- generally short acting drugs gone before too many problems occur
- drugs that bind tighter to the enzyme that are around long and cause the problems of excess ACh
- exacerbates SLUDGE M
- blurred vision, n/v/d, urination, tearing/drooling, muscle twitch/tremor, muscle paralysis
clinically: accidental exposure to pesticides